Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Celecoxib Market Research Report 2015-2025

  • HEY3832349
  • 78 Pages
  • April 2020
  • Healthcare
Download Sample    Get Discount   
 
Summary

The global Celecoxib market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

50mg Celecoxib

100mg Celecoxib

200mg Celecoxib

400mg Celecoxib

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Pfizer

Shire

Teva

Mylan

Chengdu Suncadia Pharmaceuticals

Jiangsu Chiatai Qingjiang Pharmaceutical

Anhui Heyi Chemical

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Rheumatoid Arthritis

Osteoarthritis

Acute Pain

Musculoskeletal Pain

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

Figure Celecoxib Picture

1.1.2 Specifications

Table Product Specifications of Celecoxib

1.2 Market Segment

1.2.1 by Type

Table Products Segment of Celecoxib

Table Global Celecoxib Market by Type, 2011-2022 (USD Million)

1.2.1.1 50mg Celecoxib

Table 50mg Celecoxib Overview

1.2.1.2 100mg Celecoxib

Table 100mg Celecoxib Overview

1.2.1.3 200mg Celecoxib

Table 200mg Celecoxib Overview

1.2.1.4 400mg Celecoxib

Table 400mg Celecoxib Overview

1.2.2 by Application

Table Application Segment of Celecoxib

Table Global Celecoxib Market by Application, 2011-2022 (USD Million)

1.2.2.1 Rheumatoid Arthritis

Table Rheumatoid Arthritis Overview

1.2.2.2 Osteoarthritis

Table Osteoarthritis Overview

1.2.2.3 Acute Pain

Table Acute Pain Overview

1.2.2.4 Musculoskeletal Pain

Table Musculoskeletal Pain Overview

1.2.2.5 Others

Table Others Overview

1.2.3 by Regions

Table Global Celecoxib Market by Region, 2011-2022 (USD Million)

2 Industry Chain

2.1 Industry Chain Structure

Figure Industry Chain Structure of Celecoxib

2.2 Upstream

Table Cost of Celecoxib

Figure Manufacturing Process of Celecoxib

2.3 Market

2.3.1 SWOT

Figure SWOT of Celecoxib

2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

3.1 Policy

Table Policy of Celecoxib

3.2 Economic

Table GDP of Major Countries

3.3 Technology

Table Technology of Celecoxib

3.4 Market Entry

Table Market Entry of Celecoxib

4 Market Segmentation by Type

4.1 Market Size

4.1.1 50mg Celecoxib Market, 2013-2018

Figure 50mg Celecoxib Market Size and Growth, 2015-2019 (USD Million)

Figure 50mg Celecoxib Market Size and Growth, 2015-2019 (in Volume)

Table 50mg Celecoxib CAGR by Revenue and Volume, 2015-2019

4.1.2 100mg Celecoxib Market, 2013-2018

Figure 100mg Celecoxib Market Size and Growth, 2015-2019 (USD Million)

Figure 100mg Celecoxib Market Size and Growth, 2015-2019 (in Volume)

Table 100mg Celecoxib CAGR by Revenue and Volume, 2015-2019

4.1.3 200mg Celecoxib Market, 2013-2018

Figure 200mg Celecoxib Market Size and Growth, 2015-2019 (USD Million)

Figure 200mg Celecoxib Market Size and Growth, 2015-2019 (in Volume)

Table 200mg Celecoxib CAGR by Revenue and Volume, 2015-2019

4.1.4 400mg Celecoxib Market, 2013-2018

Figure 400mg Celecoxib Market Size and Growth, 2015-2019 (USD Million)

Figure 400mg Celecoxib Market Size and Growth, 2015-2019 (in Volume)

Table 400mg Celecoxib CAGR by Revenue and Volume, 2015-2019

4.2 Market Forecast

4.2.1 50mg Celecoxib Market Forecast, 2020-2025

Figure 50mg Celecoxib Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure 50mg Celecoxib Market Estimates and Forecasts, 2020-2025 (in Volume)

Table 50mg Celecoxib CAGR by Revenue and Volume, 2012-2024

4.2.2 100mg Celecoxib Market Forecast, 2020-2025

Figure 100mg Celecoxib Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure 100mg Celecoxib Market Estimates and Forecasts, 2020-2025 (in Volume)

Table 100mg Celecoxib CAGR by Revenue and Volume, 2012-2024

4.2.3 200mg Celecoxib Market Forecast, 2020-2025

Figure 200mg Celecoxib Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure 200mg Celecoxib Market Estimates and Forecasts, 2020-2025 (in Volume)

Table 200mg Celecoxib CAGR by Revenue and Volume, 2012-2024

4.2.4 400mg Celecoxib Market Forecast, 2020-2025

Figure 400mg Celecoxib Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure 400mg Celecoxib Market Estimates and Forecasts, 2020-2025 (in Volume)

Table 400mg Celecoxib CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Rheumatoid Arthritis Market, 2013-2018

Figure Rheumatoid Arthritis Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Rheumatoid Arthritis CAGR by Revenue and Volume, 2015-2019

5.1.2 Osteoarthritis Market, 2013-2018

Figure Osteoarthritis Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Osteoarthritis CAGR by Revenue and Volume, 2015-2019

5.1.3 Acute Pain Market, 2013-2018

Figure Acute Pain Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Acute Pain CAGR by Revenue and Volume, 2015-2019

5.1.4 Musculoskeletal Pain Market, 2013-2018

Figure Musculoskeletal Pain Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Musculoskeletal Pain CAGR by Revenue and Volume, 2015-2019

5.1.5 Others Market, 2013-2018

Figure Others Market Size and Growth, 2015-2019 (USD Million)

Figure Market Size and Growth, 2015-2019 (in Volume)

Table Others CAGR by Revenue and Volume, 2015-2019

5.2 Market Forecast

5.2.1 Rheumatoid Arthritis Market Forecast, 2020-2025

Figure Rheumatoid Arthritis Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Rheumatoid Arthritis Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Rheumatoid Arthritis CAGR by Revenue and Volume, 2020-2025

5.2.2 Osteoarthritis Market Forecast, 2020-2025

Figure Osteoarthritis Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Osteoarthritis Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Osteoarthritis CAGR by Revenue and Volume, 2020-2025

5.2.3 Acute Pain Market Forecast, 2020-2025

Figure Acute Pain Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Acute Pain Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Acute Pain CAGR by Revenue and Volume, 2020-2025

5.2.4 Musculoskeletal Pain Market Forecast, 2020-2025

Figure Musculoskeletal Pain Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Musculoskeletal Pain Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Musculoskeletal Pain CAGR by Revenue and Volume, 2020-2025

5.2.5 Others Market Forecast, 2020-2025

Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Others CAGR by Revenue and Volume, 2020-2025

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2015-2019

Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)

Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019

6.1.1.2 Asia-Pacific Market by Type

Figure Asia-Pacific Market Size by Type

Figure Asia-Pacific Market Share by Type

6.1.1.3 Asia-Pacific Market by Application

Figure Asia-Pacific Market Size by Application

Figure Asia-Pacific Market Share by Application

6.1.2 North America

6.1.2.1 North America Market, 2015-2019

Figure North America Market Size and Growth, 2015-2019 (USD Million)

Figure North America Market Size and Growth, 2015-2019 (in Volume)

Table North America CAGR by Revenue and Volume, 2015-2019

6.1.2.2 North America Market by Type

Figure North America Market Size by Type

Figure North America Market Share by Type

6.1.2.3 North America Market by Application

Figure North America Market Size by Application

Figure North America Market Share by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2015-2019

Figure Europe Market Size and Growth, 2015-2019 (USD Million)

Figure Europe Market Size and Growth, 2015-2019 (in Volume)

Table Europe CAGR by Revenue and Volume, 2015-2019

6.1.3.2 Europe Market by Type

Figure Europe Market Size by Type

Figure Europe Market Share by Type

6.1.3.3 Europe Market by Application

Figure Europe Market Size by Application

Figure Europe Market Share by Application

6.1.4 South America

6.1.4.1 South America Market, 2015-2019

Figure South America Market Size and Growth, 2015-2019 (USD Million)

Figure South America Market Size and Growth, 2015-2019 (in Volume)

Table South America CAGR by Revenue and Volume, 2015-2019

6.1.4.2 South America Market by Type

Figure South America Market Size by Type

Figure South America Market Share by Type

6.1.4.3 South America Market by Application

Figure South America Market Size by Application

Figure South America Market Share by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2015-2019

Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)

Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019

6.1.5.2 Middle East & Africa Market by Type

Figure Middle East & Africa Market Size by Type

Figure Middle East & Africa Market Share by Type

6.1.5.3 Middle East & Africa Market by Application

Figure Middle East & Africa Market Size by Application

Figure Middle East & Africa Market Share by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2020-2025

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

6.2.2 North America Market Forecast, 2020-2025

Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table North America CAGR by Revenue and Volume, 2020-2025

6.2.3 Europe Market Forecast, 2020-2025

Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Europe CAGR by Revenue and Volume, 2020-2025

6.2.4 South America Market Forecast, 2020-2025

Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table South America CAGR by Revenue and Volume, 2020-2025

6.2.5 Middle East & Africa Market Forecast, 2020-2025

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

7 Market Competitive

7.1 Global Market by Vendors

Table Global Celecoxib Market by Vendors, 2015-2019 (in Volume)

Table Global Celecoxib Market Share by Vendors, 2015-2019 (USD Million)

Table Global Celecoxib Market Share by Vendors, 2015-2019 (in Volume)

7.2 Market Concentration

Figure Celecoxib Market Concentration by Region

7.3 Price & Factors

Table Price Factors List

7.4 Marketing Channel

Figure Marketing Channels Overview

8 Major Vendors

8.1 Pfizer

Table Pfizer Profile List

Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.2 Shire

Table Shire Profile List

Table Microecological Modulator Operating Data of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.3 Teva

Table Teva Profile List

Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.4 Mylan

Table Mylan Profile List

Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.5 Chengdu Suncadia Pharmaceuticals

Table Chengdu Suncadia Pharmaceuticals Profile List

Table Microecological Modulator Operating Data of Chengdu Suncadia Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.6 Jiangsu Chiatai Qingjiang Pharmaceutical

Table Jiangsu Chiatai Qingjiang Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Jiangsu Chiatai Qingjiang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

8.7 Anhui Heyi Chemical

Table Anhui Heyi Chemical Profile List

Table Microecological Modulator Operating Data of Anhui Heyi Chemical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

9 Conclusion

List of Table

Table Product Specifications of Celecoxib

Table Products Segment of Celecoxib

Table Global Celecoxib Market by Type, 2011-2022 (USD Million)

Table 50mg Celecoxib Overview

Table 100mg Celecoxib Overview

Table 200mg Celecoxib Overview

Table 400mg Celecoxib Overview

Table Application Segment of Celecoxib

Table Global Celecoxib Market by Application, 2011-2022 (USD Million)

Table Rheumatoid Arthritis Overview

Table Osteoarthritis Overview

Table Acute Pain Overview

Table Musculoskeletal Pain Overview

Table Others Overview

Table Global Celecoxib Market by Region, 2011-2022 (USD Million)

Table Cost of Celecoxib

Table Market Dynamics

Table Policy of Celecoxib

Table GDP of Major Countries

Table Technology of Celecoxib

Table Market Entry of Celecoxib

Table 50mg Celecoxib CAGR by Revenue and Volume, 2015-2019

Table 100mg Celecoxib CAGR by Revenue and Volume, 2015-2019

Table 200mg Celecoxib CAGR by Revenue and Volume, 2015-2019

Table 400mg Celecoxib CAGR by Revenue and Volume, 2015-2019

Table 50mg Celecoxib CAGR by Revenue and Volume, 2012-2024

Table 100mg Celecoxib CAGR by Revenue and Volume, 2012-2024

Table 200mg Celecoxib CAGR by Revenue and Volume, 2012-2024

Table 400mg Celecoxib CAGR by Revenue and Volume, 2012-2024

Table Rheumatoid Arthritis CAGR by Revenue and Volume, 2015-2019

Table Osteoarthritis CAGR by Revenue and Volume, 2015-2019

Table Acute Pain CAGR by Revenue and Volume, 2015-2019

Table Musculoskeletal Pain CAGR by Revenue and Volume, 2015-2019

Table Others CAGR by Revenue and Volume, 2015-2019

Table Rheumatoid Arthritis CAGR by Revenue and Volume, 2020-2025

Table Osteoarthritis CAGR by Revenue and Volume, 2020-2025

Table Acute Pain CAGR by Revenue and Volume, 2020-2025

Table Musculoskeletal Pain CAGR by Revenue and Volume, 2020-2025

Table Others CAGR by Revenue and Volume, 2020-2025

Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019

Table North America CAGR by Revenue and Volume, 2015-2019

Table Europe CAGR by Revenue and Volume, 2015-2019

Table South America CAGR by Revenue and Volume, 2015-2019

Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

Table North America CAGR by Revenue and Volume, 2020-2025

Table Europe CAGR by Revenue and Volume, 2020-2025

Table South America CAGR by Revenue and Volume, 2020-2025

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

Table Global Celecoxib Market by Vendors, 2015-2019 (in Volume)

Table Global Celecoxib Market Share by Vendors, 2015-2019 (USD Million)

Table Global Celecoxib Market Share by Vendors, 2015-2019 (in Volume)

Table Price Factors List

Table Pfizer Profile List

Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shire Profile List

Table Microecological Modulator Operating Data of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Profile List

Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Profile List

Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Chengdu Suncadia Pharmaceuticals Profile List

Table Microecological Modulator Operating Data of Chengdu Suncadia Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Jiangsu Chiatai Qingjiang Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Jiangsu Chiatai Qingjiang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Anhui Heyi Chemical Profile List

Table Microecological Modulator Operating Data of Anhui Heyi Chemical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950